Leo Brokerage’s GSK GSK Stock Holding History

Leo Brokerage’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$681K	Buy	19,118 +2,046	+12%	+$73.4K	0.08%	153
2023 Q1	$607K	Buy	+17,072	New	+$597K	0.09%	157
2022 Q2	$212K	Buy	+3,898	New	+$215K	0.06%	162

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Leo Brokerage's GSK Position: Q2 2023 in Review

Leo Brokerage increased its GSK (GSK) stake by 12% in Q2 2023, buying an estimated $73.4K and bringing the position to 19,118 shares worth $681K. The position accounts for 0.08% of the portfolio, ranked #153.

Leo Brokerage first reported a position in GSK in Q2 2022 and has held it in 3 quarters since. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

Leo Brokerage held 19,118 shares of GSK worth $681K as of Q2 2023.
Leo Brokerage bought 2,046 GSK shares in Q2 2023, an estimated $73.4K.
GSK made up 0.08% of Leo Brokerage's portfolio in Q2 2023, its #153 holding.
Leo Brokerage first reported a position in GSK in Q2 2022 and has held it in 3 quarters since.
827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on Leo Brokerage's 13F filing for Q2 2023, filed 25 Jul 2023.